D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Aerospace
GE
|
+$499M |
| 2 |
Meta Platforms (Facebook)
META
|
+$468M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$331M |
| 4 |
Merck
MRK
|
+$312M |
| 5 |
MON
Monsanto Co
MON
|
+$245M |
Top Sells
| 1 |
Apple
AAPL
|
+$440M |
| 2 |
Netflix
NFLX
|
+$300M |
| 3 |
Verizon
VZ
|
+$253M |
| 4 |
Tesla
TSLA
|
+$241M |
| 5 |
Alibaba
BABA
|
+$236M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Healthcare | 14.64% |
| 3 | Consumer Discretionary | 11.67% |
| 4 | Communication Services | 10.42% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Zimmer Biomet
ZBH
$20.2B
| $36.5M | 0.05% |
311,781
+85,605
| +38% | +$10M |
|
327
Essent Group
ESNT
$6.28B
| $35.8M | 0.05% |
824,996
-101,353
| -11% | -$4.4M |
|
328
Cimpress
CMPR
$1.4B
| $35.4M | 0.05% |
295,056
+29,926
| +11% | +$3.59M |
|
329
Amicus Therapeutics
FOLD
$2.41B
| $35.3M | 0.05% |
2,456,213
-2,049,287
| -45% | -$29.5M |
|
330
Brookdale Senior Living
BKD
$1.78B
| $35.3M | 0.05% |
3,640,346
+961,447
| +36% | +$9.33M |
|
|
DLPH
331
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $35M | 0.05% |
+666,389
| New | +$35M |
|
332
CoreCivic
CXW
$2.28B
| $34.9M | 0.05% |
1,552,176
+243,788
| +19% | +$5.49M |
|
333
Gildan
GIL
$8.17B
| $34.8M | 0.05% |
1,079,521
+240,068
| +29% | +$7.75M |
|
334
LPL Financial
LPLA
$27.6B
| $34.8M | 0.05% |
609,281
+194,170
| +47% | +$11.1M |
|
335
Alnylam Pharmaceuticals
ALNY
$60.3B
| $34.6M | 0.05% |
272,720
-709,734
| -72% | -$90.2M |
|
|
SINA
336
DELISTED
Sina Corp
SINA
| $34.6M | 0.05% |
344,560
+176,564
| +105% | +$17.7M |
|
337
Madison Square Garden
MSGS
$5.16B
| $34.5M | 0.05% |
229,270
-22,819
| -9% | -$3.43M |
|
|
CSRA
338
DELISTED
CSRA Inc.
CSRA
| $34.3M | 0.05% |
1,147,331
-330,723
| -22% | -$9.9M |
|
339
Marsh & McLennan
MMC
$98B
| $34.2M | 0.05% |
420,323
-95,901
| -19% | -$7.81M |
|
340
Edwards Lifesciences
EW
$45.6B
| $34M | 0.05% |
905,007
+176,835
| +24% | +$6.64M |
|
341
Carter's
CRI
$1.11B
| $33.9M | 0.05% |
288,702
-77,812
| -21% | -$9.14M |
|
342
MSC Industrial Direct
MSM
$5.1B
| $33.9M | 0.05% |
350,790
-147,991
| -30% | -$14.3M |
|
343
AerCap
AER
$21.5B
| $33.9M | 0.05% |
643,874
+185,107
| +40% | +$9.74M |
|
|
ANTX
344
DELISTED
Anthem, Inc.
ANTX
| $33.6M | 0.05% |
+600,000
| New | +$33.6M |
|
|
AMED
345
DELISTED
Amedisys
AMED
| $33.6M | 0.05% |
637,517
+134,151
| +27% | +$7.07M |
|
|
TMX
346
DELISTED
Terminix Global Holdings, Inc.
TMX
| $33.6M | 0.05% |
977,339
+694,916
| +246% | +$23.9M |
|
347
CMS Energy
CMS
$21.5B
| $33.3M | 0.05% |
704,869
+445,690
| +172% | +$21.1M |
|
348
Commault Systems
CVLT
$8.3B
| $33.3M | 0.05% |
634,519
+111,823
| +21% | +$5.87M |
|
349
Ecolab
ECL
$77.4B
| $33.3M | 0.05% |
248,018
-3,708
| -1% | -$498K |
|
350
Pentair
PNR
$18.3B
| $33.2M | 0.05% |
700,061
+636,120
| +995% | +$30.2M |
|